Diabetes Mellitus Clinical Trial
Official title:
Mobile Diabetes Education Teams in Primary Care
| Verified date | December 2013 |
| Source | Ryerson University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Observational |
The purpose of this study is to evaluate the implementation of the Mobile Diabetes Education
Team (MDET) intervention in the Greater Toronto Area, as well as the intervention's
effectiveness in improving patient clinical and care process outcomes.
The study's hypotheses are that the MDET intervention results in the following outcomes:
- Improvement in patient clinical outcomes;
- An increase in the proportion of primary care physicians (PCPs) performing patient care
processes according to clinical practice guidelines;
- An increase in the proportion of referrals to, and patients' utilization of, diabetes
education programs (DEPs).
| Status | Completed |
| Enrollment | 900 |
| Est. completion date | April 12, 2017 |
| Est. primary completion date | March 12, 2014 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Has Diabetes Mellitus, Type 2; - Is 18 years of age or older; - Has an HbA1c of > 8%. Exclusion Criteria: - Has type of diabetes that requires intense and specialized treatment, such as Type 1 diabetes, gestational diabetes, or patients on a multiple, daily insulin regime. |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Ryerson University | Canadian Institutes of Health Research (CIHR), Trillium Health Centre |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Change from 12 months prior to intervention in HbA1c up to 12 months during the intervention | Change in patients' results for HbA1c from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in low-density lipoprotein (LDL-C) up to 12 months during the intervention | Change in patients' results for low-density lipoprotein (LDL-C) from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in total cholesterol-high density lipoprotein ratio (TC-HDL ratio) up to 12 months during the intervention | Change in patients' results for total cholesterol-high density lipoprotein ratio (TC-HDL ratio) from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in blood pressure up to 12 months during the intervention | Change in patients' results for blood pressure from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in testing for HbA1c up to 12 months during the intervention | Change in proportion of primary care physicians testing for patients' HbA1c from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in blood pressure testing up to 12 months during the intervention | Change in proportion of primary care physicians testing for patients' blood pressure from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in lipid profile testing up to 12 months during the intervention | Change in proportion of primary care physicians testing for patients' lipid profile from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in nephropathy screening up to 12 months during the intervention | Change in proportion of primary care physicians screening patients for nephropathy (ACR and eGFR) from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in foot exams up to 12 months during the intervention | Change in proportion of primary care physicians performing foot exams from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in dilated retinal exam referrals up to 12 months during the intervention | Change in proportion of primary care physicians referring patients to dilated retinal exams from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in flu vaccine provision or recommendation up to 12 months during the intervention | Change in proportion of primary care physicians providing for, or recommending, the flu vaccine to patients from 12 months prior to intervention up to 12 months during the intervention. | At 12 months prior to intervention; up to 12 months during the intervention | |
| Secondary | Change from 12 months prior to intervention in Diabetes Education Program referrals at 12 months of intervention | Change in primary care physicians' referrals to, and patients' utilization of, diabetes education programs from 12 months prior to the intervention at 12 months of the intervention. | 12 months prior to intervention to 12 months of the intervention | |
| Secondary | Patient attendance at scheduled MDET visits | Number of MDET appointments planned for each patient compared to the number of MDET visits attended. | At 12 months of intervention | |
| Secondary | Collaborative Practice Assessment Tool scores of PCPs and MDET educators in intervention | Collaborative Practice Assessment Tool scores of PCPs and MDET educators at 12 months of the intervention, to assess interprofessional collaboration between PCPs and educators. | At 12 months of intervention | |
| Secondary | Patients' interview responses regarding intervention effectiveness | In-depth interview responses of 20 randomly-selected patients at 12 months of the intervention, regarding the usefulness of the intervention in better understanding their condition, diabetes self-management strategies, and convenience and quality of delivery. | At 12 months of intervention | |
| Secondary | PCPs' interview responses regarding interprofessional collaboration in, and the implementation of, the intervention | In-depth interview responses of 16 randomly-selected PCPs at 12 months of the intervention, regarding their experiences with the intervention, their collaboration and teamwork, barriers and facilitators to implementation, and suggestions to improve the intervention. | At 12 months of intervention | |
| Secondary | MDET educators' interview responses regarding interprofessional collaboration in, and the implementation of, the intervention | In-depth interview responses of 16 randomly-selected educators at 12 months of the intervention, regarding their experiences with the intervention, their collaboration and teamwork, barriers and facilitators to implementation, and suggestions to improve the intervention. | At 12 months of intervention | |
| Secondary | MDET educators' reflective journal responses regarding interprofessional collaboration in, and the implementation of, the intervention | MDET educators' monthly field notes in their reflective journals regarding their experiences and reflections of those experiences with the implementation of, and interprofessional collaboration in, the intervention. | Up to 2 years | |
| Secondary | MDET educators' quarterly debriefing session group discussions regarding intervention issues | MDET educators' group discussions during MDET debriefing sessions, held quarterly, regarding any issues with the implementation of the intervention. | Up to 2 years |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
| Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
| Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
| Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
| Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
| Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
| Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
| Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
| Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
| Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
| Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
| Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
| Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
| Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
| Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
| Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
| Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
| Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |